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gamma-aminobutyric acid by Corynebacterium
glutamicum expressing glutamate decarboxylase
Naoko Okai1†, Chihiro Takahashi2†, Kazuki Hatada2, Chiaki Ogino2 and Akihiko Kondo2*Abstract
Gamma-aminobutyric acid (GABA), a building block of the biodegradable plastic polyamide 4, is synthesized from
glucose by Corynebacterium glutamicum that expresses Escherichia coli glutamate decarboxylase (GAD) B encoded
by gadB. This strain was engineered to produce GABA more efficiently from biomass-derived sugars. To enhance
GABA production further by increasing the intracellular concentration of its precursor glutamate, we focused on
engineering pknG (encoding serine/threonine protein kinase G), which controls the activity of 2-oxoglutarate
dehydrogenase (Odh) in the tricarboxylic acid cycle branch point leading to glutamate synthesis. We succeeded
in expressing GadB in a C. glutamicum strain harboring a deletion of pknG. C. glutamicum strains GAD and GAD
ΔpknG were cultured in GP2 medium containing 100 g L−1 glucose and 0.1 mM pyridoxal 5′-phosphate. Strain
GADΔpknG produced 31.1 ± 0.41 g L−1 (0.259 g L−1 h−1) of GABA in 120 hours, representing a 2.29-fold higher
level compared with GAD. The production yield of GABA from glucose by GADΔpknG reached 0.893 mol mol−1.
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dehydrogenase; Protein kinase GIntroduction
Diverse microorganisms, animals, and plants synthesize
the amino acid gamma-aminobutyric acid (GABA), which
does not naturally occur in proteins. GABA functions
as a neurotransmitter in humans, lowers blood pressure
(Hayakawa et al. 2004), and is a component of pharma-
ceuticals and foods (Li and Cao 2010). The bioplastic
polyamide 4 (PA4) is a linear polymer of GABA, which
is chemically synthesized from the GABA lactam 2-
pyrrolidone (Kawasaki et al. 2005). PA4 has excellent
physical properties based on its high melting point of
260°C and its degradability by microbes in soil (Hashimoto
et al. 1994) and activated sludge (Yamano et al. 2008). The
synthesis of GABA from abundantly available biomass
by recombinant microorganisms will make it possible
to produce new bioplastics at low cost.* Correspondence: akondo@kobe-u.ac.jp
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in any medium, provided the original work is pGlutamate decarboxylase (GAD; EC 4.1.1.15) catalyzes
the conversion of L-glutamate to GABA through alpha-
decarboxylation (Fonda 1985). Genes (gad) encoding
GAD are present in Escherichia coli (DeBiase et al. 1996),
Lactobacillus brevis (Oda et al. 2008), Lactobacillus
paracasei (Shima et al. 2008), and several other species
of Lactobacillus as well as Enterobacteria. Lactic acid
bacteria produce GABA when glutamate is added to the
fermentation medium. Although the quantities of GABA
produced by this method are sufficient for producing
foods, it is not cost-effective for producing chemicals.
Therefore, we developed a robust system for producing
GABA from saccharides by expressing E. coli GAD in
Corynebacterium glutamicum (Takahashi et al. 2012).
The biotin auxotroph C. glutamicum is a nonpathogenic,
nonsporulating, nonmotile, Gram-positive soil bacterium
that belongs to the order Actinomycetales, which includes
Corynebacteria, Nocardia, Rhodococci, and other related
microorganisms (George 2001). C. glutamicum is an im-
portant industrial microorganism, because it produces
high levels of glutamate and other amino acids, which
are widely used in pharmaceuticals, animal feed, and foodOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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To efficiently produce GABA, the gadB gene from E. coli
W3110 was overexpressed in a glutamate-producing C.
glutamicum strain (ATCC 13032). After optimization, this
strain produced 12.37 g L−1 of GABA from glucose in
the presence of pyridoxal 5′-phosphate in the absence
of added glutamate (Takahashi et al. 2012).
In the present study, we further enhanced GABA synthe-
sis using recombinant C. glutamicum strains expressing
GAD to optimize the intracellular level of glutamate.
To increase the flux of 2-oxoglutarate to glutamate, we
attempted to disrupt pknG, which affects the activity of
2-oxoglutarate dehydrogenase (Odh). The reduction of
the 2-oxoglutarate dehydrogenase complex (ODHC) is an
important factor for glutamate synthesis by C. glutamicum
(Kimura 2002). ODHC participates in the tricarboxylic
acid (TCA) cycle and catalyzes the conversion of 2-
oxoglutarate to succinyl-CoA. The ODHC comprises
four subunits, OdhI, OdhA, AceF, and Lpd. The activity
of C. glutamicum ODHC is controlled by a regulatory
mechanism that involves OdhI and serine/threonine
protein kinase G (PknG, EC 2.7.11.1) (Schultz et al.
2009). PknG catalyzes the phosphorylation of OdhI, a
15 kDa subunit of ODHC. Unphosphorylated OdhI
binds the EI subunit (OdhA) of ODHC and inhibits its
activity. Inhibition of ODHC activity is reversed by
phosphorylation of OdhI at threonine residue 14 by
PknG (Niebisch et al. 2006). The pknG-deficient mu-
tant produces glutamate at a higher rate compared with
the parental C. glutamicum strain, suggesting that the
mutations influence ODHC activities (Schultz et al.
2007; Boulahya et al. 2010).
In the present study, a pknG-deficient C. glutamicum
strain expressing GAD was generated to increase the flux
of 2-oxoglutarate towards glutamate for more efficient
biosynthesis of GABA. Using this strain, we were able to
produce significantly higher levels of GABA from glucose.
Materials and methods
Bacterial strains and media
The bacterial strains and plasmids used in this study are
listed in Table 1. E. coli strains were grown in Luria-Bertani
medium (10 g L−1 tryptone, 5 g L−1 yeast extract, and
5 g L−1 sodium chloride) containing 50 μg mL−1 kanamycin
at 37°C. C. glutamicum ATCC 13032 and all recombinant
strains were grown in brain–heart infusion (BHI) medium
(Becton, Dickinson and Co., Franklin Lakes, NJ, USA). BHI
medium supplemented with 25 μg mL−1 kanamycin and
1.5% agar was used to select C. glutamicum transformants.
The transformants were first cultivated at 30°C for
24 hours in a test tube containing 5 mL BHI medium with
25 μg mL−1 kanamycin and then inoculated into 20 mL
GP2 medium (Takahashi et al. 2012) containing
25 μg mL−1 kanamycin in a 200-mL flask for fermentation.Molecular genetic techniques
E. coli SCS110 was used to avoid DNA methylation, and
polymerase chain reaction (PCR) was conducted using
KOD-Plus2 DNA polymerase (Toyobo, Osaka, Japan).
Plasmid DNA was purified using a LaboPass™ Plasmid
Mini Purification Kit (Cosmo Bio Co., Ltd., Tokyo, Japan).
Construction of plasmids for disrupting pknG
Genomic DNA was purified using the Wizard Genomic
DNA Purification Kit (Promega, Madison, WI, USA)
from C. glutamicum ATCC 13032 grown in BHI medium.
The oligonucleotide primers used in this study are listed
in Table 2. To inactivate pknG (KEGG Entry NCgl 2655,
Gene Name Cgl 2751, 2469 nt), an 801-base pair (bp)
upstream region of pknG (pknG-up) was amplified using
PCR with the primer pair pknG-up-In-F and pknG-up-In-
R-801 and strain ATCC 13032 genomic DNA as template.
An 800-bp downstream region of pknG (pknG-down)
was amplified using PCR with the primer pair pknG-up-
In-F-1669 and pknG-down-In-R. The two fragments,
pknG-up and pknG-down, were fused using overwrap
PCR using the primer pair pknG-In-F2 and pknG-In-R2,
yielding a 1,601-bp fragment of pknG. The amplified DNA
fragment was purified from a 1.0% agarose gel using the
Wizard SV Gel and PCR Clean-Up systems (Promega).
The plasmid pTM44 (Mimitsuka et al. 2007), which
contains sacB from B. subtilis, was used as a suicide
vector for markerless gene disruption and was digested
with SphI and BamHI (New England BioLabs Inc., MA,
USA) to remove a 1,344-bp SphI-BamHI fragment. The
1.60-kbp ΔpknG fragment was inserted into SphI-BamHI-
digested pTM44 using an In Fusion HD Cloning Kit (Clon-
tech Laboratories Inc., Mountain View, CA, USA), yielding
pTM44-ΔpknG. The DNA sequences of the constructs
were determined using an ABI PRISM 3100 Genetic
Analyzer (Life Technologies, Carlsbad, CA, USA).
Construction of C. glutamicum pknG deletion mutants
C. glutamicum ATCC 13032 was transformed with pTM
44-ΔpknG using a Gene Pulser Xcell electroporator
(Bio-Rad, Richmond, CA, USA) (2.5 kV, 25 μF electric
pulse in a 0.1-cm cuvette) followed by heat shock at 46°C
for 6 min. The cells were then incubated in 1 mL of
BHI medium at 30°C for 1.5 hours. After cultivation for
2 days at 30°C on BHI agar plates containing 25 μg mL−1
kanamycin, the transformants were selected for a strain
with a single crossover of the ΔpknG genotype, which was
then cultivated in 5 mL of BHI liquid medium at 30°C
overnight and diluted 1:10,000 with MM medium (see
below) containing 10% sucrose. The culture was plated on
MM agar medium containing 10% sucrose and incubated
for 2 days at 30°C. MM medium contains 1 g Yeast
Extract, 10 g (NH4)2SO4, 1 g KH2PO4, 3 g urea, 0.4 g
MgSO4∙7H2O, 2 mg FeSO4∙7H2O, 2 mg MnSO4∙5H2O,
Table 1 Bacterial strains and plasmids
Bacterial strains or plasmids Relevant characteristics Reference or source
E. coli
SCS110 rpsL (Strr) thr leu endA thi-l lacY galK galT ara tonA tsx dam dcm Stratagene
supE44Δ (lac-proAB) [F’traD36 proAB laclqZΔM15]
C. glutamicum
ATCC 13032 Wild-type C. glutamicum, biotin-auxotrophic, L-glutamate producing strain ATCC
W Wild-type C. glutamicum derivative harboring pCH Takahashi et al. 2012
GAD Wild-type C. glutamicum derivative harboring pCH-gadB Takahashi et al. 2012
ΔpknG Wild-type C. glutamicum derivative with deletion in pknG This study
GADΔpknG Wild-type C. glutamicum derivative with deletion in pknG, harboring pCH-gadB This study
Plasmids
pCH E. coli-C. glutamicum shuttle vector with HCE promoter, Kmr Tateno et al. 2007
pCH-gadB pCH containing gadB from E.coli W3110, Kmr Takahashi et al. 2012
pTM44 pHSG298 with B. subtilis sacB and C. glutamicum hom, Kmr Mimitsuka et al. 2007
pTM44-ΔpknG pTM44 with 1,601-bp SphI-BamHI fragment with deletions of pknG, Kmr This study
r antibiotic resistance.
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liter. The occurrence of a double-crossover ΔpknG
mutant was confirmed by its inability to grow after
1 day at 30°C on MM agar containing 25 μg mL−1
kanamycin. The sizes of ΔpknG (1.60-kbp) in the C.
glutamicum genome was confirmed using directed
PCR with the primer pairs used for the construction
and KOD FX (Toyobo). The selected double-crossover
strain was designated C. glutamicum ΔpknG.
Construction of C. glutamicum mutants that express GAD
The construction of the GAD-expression plasmid pCH-
gadB, C. glutamicum GAD (strain ATCC 13032 harboring
pCH-gadB), and C. glutamicum W (strain ATCC13032
harboring pCH) was reported (Takahashi et al. 2012).
Plasmid pCH is an E. coli-C. glutamicum shuttle vector
that drives gene expression with a highly active consti-
tutive promoter (Tateno et al. 2007). The pCH-gadB
construct was introduced into C. glutamicum ΔpknG.
Transformants were selected by growth on BHI agar
containing 25 μg mL−1 kanamycin. The presence of gadBTable 2 Oligonucleotide primers









Restriction enzyme cleavage sites are shown in small letters, and complementary sequwas confirmed using directed PCR with the primer
pair SacI-gadB-F and XhoI-gadBF-R. The resulting strain,
C. glutamicum ΔpknG (pCH-gadB) was designated C.
glutamicum GADΔpknG.
Western blotting analysis
C. glutamicum strains W, GAD, and GADΔpknG were
cultured in test tubes at 30°C for 24 hours in 5 mL BHI
medium containing 25 μg mL−1 kanamycin. Each culture
(0.2 mL) was transferred to 20 mL BHI medium contain-
ing 25 μg mL−1 kanamycin in a 200 mL shaker flask. After
fermentation for 24 hours, the cells from a 1 mL culture
were centrifuged at 8,000 × g for 5 min, washed once in
50 mM Tris–HCl (pH 6.8) buffer, suspended in 1 mL
of this buffer, and then 0.7 g of 0.1-mm diameter glass
beads YGB01 (Yasui Kikai, Japan) was added to the
tube. The cells were disrupted using a Shake Master
Neo (Bio Medical Science) by shaking the tube three
times at 1,500 rpm for 1 min at 1-min intervals. After
centrifugation at 9,000 × g for 5 min, the supernatants









ences of the primer pairs used for overlap-extension PCR are shown in italics.
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electroblotted onto a polyvinylidene fluoride membrane
(Millipore, Boston, MA, USA) and then reacted sequen-
tially with a mouse anti-FLAG M2 monoclonal antibody
(Sigma, St. Louis, MO, USA) and a goat anti-mouse
IgG alkaline phosphate conjugate (Promega) secondary
antibody. The membrane was stained with 4-nitro-blue
tetrazolium chloride (Promega) and 5-bromo-4-chloro-3-
indolyl phosphate (Promega) according to the manufac-
turer’s instructions.
Culture conditions for GABA fermentation from glucose
To produce GABA, C. glutamicum GAD and the mutant
strains were cultured in a test tube at 30°C for 22 hours
in 5 mL BHI medium containing 25 μg mL−1 kanamycin.
This culture (0.2 ml) was transferred to a 200 mL shaker
flask containing 20 mL GABA Production 2 (GP2) medium
with 25 μg mL−1 of kanamycin. GP2 medium contains
50 g glucose, 50 g (NH4)2SO4, 1 g K2HPO4, 3 g urea,
0.4 g MgSO4∙7H2O, 50 g soypeptone, 0.01 g FeSO4∙7H2O,
0.01 g MnSO4∙5H2O, 200 μg thiamine, 0.5 mg biotin, and
0.265 g pyridoxal 5′-phosphate (PLP) L−1. Stock solutions
of thiamine, biotin, and PLP were filtered through a
0.22 μm membrane and added to the medium before
adding cells. The initial pH of the GP2 medium was
6.30. The pH of the GP2 medium was not adjusted during
the fermentation. The fermentation was performed in a
BR-13FR BioShaker (Taitec, Japan) at 30°C at 120 rpm.
To determine the effect of adding glutamate (Figure 1),
C. glutamicum GAD was cultured for 96 hours, and
1 g L−1 or 2 g L−1 of glutamate was added to the culture at
24 hours. To determine the effect of the pknG deletion on
GABA production (Figure 2), C. glutamicum GAD and C.
glutamicum GAD ΔpknG were cultivated for 96 hours. C.
glutamicumW served as a control.
To determine the yield of GABA, fermentation was
performed using strains GAD and GADΔpknG. The strains
were cultivated in BHI medium at 30°C for 24 hours, and
5% (w/v) of the starter-culture solution was transferred to
a 200 mL baffled flask containing 20 mL GP2 medium
with 100 g L−1 glucose and 25 μg mL−1 kanamycin, and
agitated at 120 rpm for 168 hours (Figure 3).
Throughout cultivation, 1 ml of the culture was collected
from each flask every 24 hours, centrifuged at 8,000 × g for
5 min at 4°C, and filtered through a 0.45 μm DISMIC
Mixed Cellulose Ester (Advantec, Tokyo, Japan). The
concentrations of GABA, glutamate, and glucose in culture
supernatants were analyzed as described below. The optical
density at 600 nm (OD600) was monitored simultaneously.
Analysis of cell growth, production of GABA and
L-glutamate, and consumption of glucose
The growth of the C. glutamicum strains was monitored at
OD600 using a UVmini-1240 UV–vis spectrophotometer(Shimadzu, Kyoto, Japan). GABA and L-glutamate con-
centrations in the supernatant were analyzed using a
Shim-pack Amino-Li column (0.5 μm, 100 mm × 6.0 mm
I.D, Shimadzu) and a Prominence Amino Acid Analyzer
System (Shimadzu) after derivatization with ortho-phtha-
laldehyde. The mobile phase (lithium citrate-borate gradient
ranging from pH 2.68–10.00) was delivered at 0.6 mL min−1
at 39°C. Amino acid mixtures Type AN-II and Type B
(Wako Chemicals, Japan), 0.1 mM GABA (Nacalai Tesque),
and 0.1 mM L-glutamate in sodium citrate buffer (pH 2.2)
served as standards. Glucose concentrations were deter-
mined using a Prominence HPLC System (Shimadzu)
equipped with an Shim-Pac SPR-Pb column (0.5 μm,
250 mm × 4.0 mm I.D., Shimadzu). Water served as
the mobile phase and was delivered at a flow rate of
0.6 mL min−1 at 80°C. The elution profile was monitored
using a refractometer.Results
Effect of exogenous L-glutamate on GABA fermentation
by C. glutamicum GAD
To examine the effect of glutamate as a precursor for
GABA synthesis, L-glutamate was added to a culture of
C. glutamicum GAD grown on GP2 medium with glucose
as the primary carbon source, soy peptone as the nitrogen
source, and the GAD cofactor PLP (Figure 1). The culture
supernatant was periodically assayed for GABA, glucose,
and glutamate (Figure 1). L-Glutamate was added to the
culture of C. glutamicum GAD after 24 hours, and a paral-
lel control culture lacked added L-glutamate (Figure 1B).
The concentrations of GABA after 96 h of fermentation
were 9.52 ± 1.14, 8.55 ± 0.2, and 7.49 ± 2.14 g L−1 in media
containing either 2 g L−1, 1 g L−1 L-glutamate, or no
glutamate, respectively. The maximum concentration
of GABA produced by strain GAD in the presence of
2 g L−1 L-glutamate was 10.47 ± 0.41 g L−1 after 72 h
(Figure 1A). The glutamate concentration in the medium
of each culture decreased after 24 hours (Figure 1B), and
the addition of glutamate was effective for prolonging
GABA production.Expression of GAD by pknG deletion mutants
C. glutamicum ΔpknG was constructed as described in
the Materials and methods section. The GAD-expression
plasmid pCH-gadB was introduced into C. glutamicum
ΔpknG, and the resultant recombinant strain harboring
pCH-gadB was named C. glutamicum GADΔpknG. C.
glutamicum strains GAD and W served as controls. The
intracellular expression levels of GAD in the engineered
C. glutamicum strains were monitored by western blotting
analysis using an antibody raised against the FLAG-tagged
sequence that was incorporated into the cloned genes.

















































Figure 1 Effect of glutamate on GABA production by C. glutamicum GAD. To examine the effect of adding L-glutamate during GABA
fermentation, C. glutamicum GAD was cultured in 20 mL GP2 medium containing 25 μg mL−1 kanamycin in a shaker flask at 30°C for 96 hours.
At 24 hours, 1.0 g L−1 (triangle) or 2.0 g L−1 (circle) of L-glutamate was added to the culture. GP2 medium without glutamate (diamond) served
as a control. A: Extracellular GABA (solid line) and glucose (dotted line) levels in each flask were monitored for 96 hours. B: Extracellular glutamate
production by C. glutamicum GAD in each flask was monitored throughout the fermentation. Data are expressed as the mean and standard error
from three independent experiments.
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GADΔpknG, but not strain W (data not shown).Influence of the pknG deletion on GABA synthesis
We next examined the effect of the pknG deletion on
GABA production from glucose, using C. glutamicum
strains GAD, GADΔpknG, and W. As glucose was con-
sumed, GABA formation was detected in the media from
cultures of each during stationary phase (Figure 2A). The
GABA concentration in the supernatants of cultures of
strain GADΔpknG reached 8.48 ± 0.30 g L−1 in 72 hours
while strain GAD produced 5.79 ± 0.20 g L−1 of GABA
(Figure 2A). The yield of GABA produced by strain
GADΔpknG was 1.46-fold higher compared with that
of strain GAD, suggesting that the pknG deletion reduced
























Figure 2 Time course of extracellular GABA production by C. glutamicu
The three strains were cultured separately in 20 mL of GP2 medium containin
flask. Fermentation was performed at 30°C for 96 hours at 120 rpm. A: Extrace
of C. glutamicum strains GAD ΔpknG (closed symbols) and GAD (open symbo
line) of strain W were monitored as controls. B: The OD600 values of C. glutam
monitored throughout the fermentation. Data are expressed as the mean andUnder these fermentation conditions, strains GADΔpknG
and GAD consumed 44.92 g L−1 and 46.39 g L−1 of glu-
cose within 72 hours, respectively (Figure 2A). The yields
of GABA from glucose by strains GADΔpknG and GAD
reached 0.337 mol mol−1 and 0.233 mol mol−1, respect-
ively, in 72 hours. The growth rates of strain GADΔpknG
were lower than that of strain GAD (Figure 2B). GABA
formation was not observed in the culture medium of
strain W (Figure 2A).GABA fermentation by GAD and GADΔpknG
To evaluate GABA production, strains GAD, and GA
DΔpknG were separately cultivated in GP2 medium
containing 100 g L−1 of glucose using baffled flasks
(Figure 3). As glucose in the GP2 medium consistently






















m strains GAD ΔpknG, C. glutamicum GAD, and C. glutamicum W.
g 50 g L−1 glucose and 25 μg mL−1 kanamycin using a 200-mL shaker
llular GABA concentrations (circles) and glucose consumption (diamonds)
ls) were monitored. GABA (squares) and glucose consumption (dotted
icum strains GAD ΔpknG (closed triangles) and GAD (open triangles) were



























































Figure 3 Time course of extracellular GABA production by C. glutamicum GAD, and GADΔpknG from 100 g L−1 glucose. C. glutamicum
strains GAD, and GADΔpknG were cultured separately in 20 mL of GP2 medium containing 100 g L−1 glucose and 25 μg mL−1 kanamycin in 200-mL
baffled flasks. Fermentation was performed at 30°C for 168 hours at 120 rpm. A: Extracellular GABA concentrations (closed symbols) and glucose
concentrations (open symbols) of C. glutamicum strains GAD (squares) and GADΔpknG (circles ) were monitored. B: Extracellular glutamate concentrations
(open symbols) and the OD600 (closed symbols) of the C. glutamicum strains GAD (squares), and GADΔpknG (circles) were monitored throughout the
fermentation. Data are expressed as the mean and standard error from three independent experiments.
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glutamicum GADΔpknG simultaneously increased, reach-
ing a maximum level of 31.16 ± 0.41 g L−1 after 120 hours
(Figure 3A). The rate of GABA production by C. glutami-
cum GADΔpknG reached 0.259 (g L−1 h−1). As 60.90 ±
4.89 g L−1 of glucose was consumed by GADΔpknG in
120 hours, the molar yield of GABA from glucose reached
0.893 mol mol−1 (Table 3). At the same time, strain
GAD produced 13.06 ± 0.45 g L−1 of GABA in 120 hours,
consuming 83.62 ± 2.92 g L−1 of glucose (Figure 3A,
Table 3), The glucose consumption rate of strain
GADΔpknG was lower than that of strain GAD (Figure 3A).
The molar yield of GABA from glucose by strain GAD was
0.272 mol mol−1 in 120 hours. Therefore, the yield of
GABA produced by C. glutamicum GADΔpknG increased
2.29-fold compared with that of C. glutamicum GAD
(Table 3). The growth rate of strain GADΔpknG was
lower than that of strain GAD. Extracellular L-glutamate
was not produced by either strain GAD or GADΔpknG
using these fermentation conditions (Figure 3B).Discussion
In the present study, we established a robust system for
producing GABA by deleting pknG from a strain of C.Table 3 Growth (OD600), GABA formation (gL−1, gL−1 h−1)
and yield (mol GABA mol glucose−1) of C. glutamicum
strains producing GABA for 120 hours
C. glutamicum strain GAD GADΔpknG
OD600 71.86 ± 0.59 40.56 ± 1.05
Glucose consumed (gL−1) 83.62 ± 2.92 60.90 ± 4.89
GABA (gL−1) 13.06 ± 0.45 31.16 ± 0.41
Relative difference 1 2.29
GABA (gL−1 h−1) 0.108 0.259
Yield (mol GABA mol glucose−1) 0.272 0.893glutamicum that overexpresses GAD. In our previous
study, GAD was introduced into wild-type C. glutamicum,
because it overproduces the GABA precursor L-glutamate
from sugar, whereas GABA is produced by C. glutamicum
GAD directly from glucose. In our optimized conditions
for GABA fermentation, GP2 medium contains biotin
to support growth. The production of GABA suggests
that intracellular glutamate is converted to GABA by
strain GAD (Takahashi et al. 2012). Wild-type C. gluta-
micum does not produce glutamate under ordinary cul-
ture conditions unless glutamate secretion is induced
by culturing the biotin-auxotrophic wild-type strain in
biotin-limiting conditions (Shiio et al. 1962). Moreover,
when L-glutamate was added to cultures of C. glutamicum
GAD to determine its effect on GABA fermentation, an
increase in the levels of GABA in the medium was ob-
served when 2 g L−1 of L-glutamate was added (Figure 1A).
We reasoned that because glutamate is a precursor in the
synthesis of GABA, its increased availability would en-
hance the yield of GABA. Based on this rationale, we were
able to successfully generate a C. glutamicum mutant that
produced relatively high levels of GABA.
We focused on pknG, because its product (PknG) reg-
ulates the activity of ODHC. PknG activates ODHC by
phosphorylating its subunit OdhI, which is a subunit of
ODHC. ODHC acts at a branch point of the TCA cycle
where it catalyzes the conversion of 2-oxoglutarate to
succinyl-CoA. Unphosphorylated OdhI inhibits the ODHC
activity of C. glutamicum (Niebisch et al. 2006). A pknG-
deficient mutant of C. glutamicum produces 4.3-fold higher
amounts of glutamate compared with wild-type under
biotin-limiting conditions (Schultz et al. 2007). The C.
glutamicum 2262 pknG mutant also produces glutamate
at a 40% higher specific rate compared with wild-type
(Boulahya et al. 2010). Therefore, a pknG-deficient strain
was constructed to reduce the metabolic flux to the
TCA cycle.
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strain GADΔpknG was 2.29-fold higher in 120 hours
compared with that of strain GAD (Figure 3, Table 3),
suggesting that the pknG deletion influenced ODHC
activity by causing an increase in the intracellular
glutamate level that enhanced GABA production. We
assumed that the ODHC activity of strain GADΔpknG
was reduced, because OdhI was not phosphorylated
and could not activate the ODHC complex, which
caused an increase in carbon flux into the glutamate
pathway compared with that of strain GAD. The glucose
consumption rate and growth rate of GADΔpknG was
lower than that of GAD (Figure 3, Table 3), suggesting that
the flux to TCA cycle was decreased. We plan to analyze
carbon flux of these strains in the future. Moreover, in the
late stage of fermentation, reduction of GABA production
was observed in cultures of strain GADΔpknG (Figure 3A).
Because reduced levels of the product were also observed
in cultures of strain GAD (Takahashi et al. 2012), we
are now attempting to disrupt the genes for GABA
assimilation.
In our GABA production system using C. glutamicum
GADΔpknG, high concentrations of GABA were pro-
duced from glucose in GP2 medium without the addition
of glutamate. The yield of GABA from glucose produced
by strain GADΔpknG reached 0.893 mol mol−1, and the
highest yield was produced in 120 hours (Table 3). Using
C. glutamicum GADΔpknG, we expect that fewer fermen-
tation by-products will be produced and that the recovery
of GABA will be simpler than using methods for its isola-
tion from cultures of wild-type lactic acid bacteria.
GABA is primarily produced using cultures of lactic acid
bacteria containing glutamate or monosodium glutamate
(MSG) (Li and Cao 2010). For example, Streptococcus
salivarius subsp. thermophilus Y2, a cheese starter strain,
produces 7.98 g L−1 of GABA after 84 hours of fer-














Figure 4 Model of direct GABA production by C. glutamicum GADΔpkcorresponding to a rate of 0.095 g L−1 hour−1 (Lu et al.
2008). L. paracasei NFRI 7415, which was isolated from
fermented fish, produces 31.11 g L−1 (302 mM) GABA in
168 hours, corresponding with a production rate of
0.185 g L−1 hour−1. Although the production rate by strain
NFRI 7415 was relatively high, 500 mM (73.5 g L−1)
glutamate was added to the culture medium (Shima
et al. 2005). L. brevis NCL912, which was isolated from
Paocai, produces 345.83 mM (35.6 g L−1) GABA in a
medium containing 500 mM glutamate (Cao et al. 2010).
Microbial production systems that require supplemen-
tation with amino acids are not cost-effective for appli-
cations such as synthesizing chemicals. In contrast, in
our GABA production system using C. glutamicum
GADΔpknG, high concentrations of GABA were pro-
duced from glucose in one step (31.16 g L−1 from glucose
at 0.259 g L−1 h−1 and therefore will provide a new plat-
form for synthesizing chemicals.
Recently, two GADs from L. brevis were expressed in
C. glutamicum ATCC 13032/pDXW-8-gadRBC2, which
produced 27.13 ± 0.54 g L−1 of GABA from glucose in
120 hours using flask fermentation with six urea supple-
ments to the medium during the fermentation (Shi et al.
2013). With urea supplementation, increased amounts of
glutamate were produced in the culture supernatant at
the same time; however, it may be difficult to separate
the product from the medium. In our system, 31.16 g L−1
of GABA was directly produced from glucose without
addition of a nitrogen or carbon source during the fermen-
tation. Notably, because our GP2 medium contains biotin
to support growth, glutamate is not secreted (Figures 3B
and 4). A one-step production system has long been a goal
for producing precursors for synthesizing bulk chemicals,
and we show here that this was possible for robust produc-
tion of GABA using GADΔpknG.
Our future work involves the development of a process
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http://www.amb-express.com/content/4/1/20cellulose. We developed a system for coexpressing amylase
and lysine decarboxylase in C. glutamicum to produce ca-
daverine from soluble starch (Tateno et al. 2009). Further,
our C. glutamicum endoglucanase secretion systems for
producing glutamate from beta glucan (Tsuchidate et al.
2011) can be applied to the production of GABA. The
production of GABA using strains based on C. glutami-
cum GADΔpknG would allow the synthesis of 100%
biomass-derived nylon PA4. Notably, C. glutamicum is
generally recognized as safe (GRAS) according the
United States Food and Drug Administration. There-
fore, the system for GABA fermentation developed in
the present study can be applied to the production of
GABA as a component of foods and pharmaceuticals.
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